PL1981851T3 - Inhibitory kinazy i sposoby ich stosowania - Google Patents
Inhibitory kinazy i sposoby ich stosowaniaInfo
- Publication number
- PL1981851T3 PL1981851T3 PL07762713T PL07762713T PL1981851T3 PL 1981851 T3 PL1981851 T3 PL 1981851T3 PL 07762713 T PL07762713 T PL 07762713T PL 07762713 T PL07762713 T PL 07762713T PL 1981851 T3 PL1981851 T3 PL 1981851T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- kinase inhibitors
- kinases
- prodrugs
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76371206P | 2006-01-31 | 2006-01-31 | |
EP07762713A EP1981851B1 (en) | 2006-01-31 | 2007-01-26 | Kinase inhibitors and methods of use thereof |
PCT/US2007/002272 WO2007089646A1 (en) | 2006-01-31 | 2007-01-26 | Kinase inhibitors and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1981851T3 true PL1981851T3 (pl) | 2012-07-31 |
Family
ID=38037453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07762713T PL1981851T3 (pl) | 2006-01-31 | 2007-01-26 | Inhibitory kinazy i sposoby ich stosowania |
Country Status (27)
Country | Link |
---|---|
US (2) | US8044083B2 (pl) |
EP (1) | EP1981851B1 (pl) |
JP (1) | JP5131990B2 (pl) |
KR (1) | KR101357465B1 (pl) |
CN (1) | CN101415685B (pl) |
AT (1) | ATE542800T1 (pl) |
AU (1) | AU2007210073B2 (pl) |
BR (1) | BRPI0707401B8 (pl) |
CA (1) | CA2635813C (pl) |
CY (1) | CY1112770T1 (pl) |
DK (1) | DK1981851T3 (pl) |
ES (1) | ES2379656T3 (pl) |
HK (1) | HK1123548A1 (pl) |
HR (1) | HRP20120256T1 (pl) |
IL (3) | IL192949A (pl) |
MY (1) | MY151835A (pl) |
NZ (1) | NZ570846A (pl) |
PL (1) | PL1981851T3 (pl) |
PT (1) | PT1981851E (pl) |
RS (1) | RS52298B (pl) |
RU (1) | RU2442777C2 (pl) |
SG (1) | SG175599A1 (pl) |
SI (1) | SI1981851T1 (pl) |
TW (1) | TWI388557B (pl) |
UA (1) | UA94733C2 (pl) |
WO (1) | WO2007089646A1 (pl) |
ZA (1) | ZA200806507B (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
EP1981851B1 (en) | 2006-01-31 | 2012-01-25 | Array Biopharma, Inc. | Kinase inhibitors and methods of use thereof |
US8202899B2 (en) * | 2007-07-25 | 2012-06-19 | Array Biopharma Inc. | Pyrazole urea derivatives used as kinase inhibitors |
EP2196461A1 (de) | 2008-12-15 | 2010-06-16 | Bayer CropScience AG | 4-Amino-1,2,3-benzoxathiazin-Derivate als Pestizide |
NZ618795A (en) | 2011-05-13 | 2015-07-31 | Array Biopharma Inc | Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors |
MY183153A (en) | 2012-03-01 | 2021-02-16 | Array Biopharma Inc | Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1h-pyrazol-5-yl) -3-(5-fluoro-2-(1-(2-hydroxyethyl)-indazol-5-yloxy)benzyl) urea hydrochloride |
CN105073739B (zh) * | 2013-02-27 | 2017-10-24 | 阵列生物制药公司 | 用于制备吲唑衍生物的中间体及其制备方法 |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
SG11202003035SA (en) | 2017-10-05 | 2020-04-29 | Fulcrum Therapeutics Inc | Use of p38 inhibitors to reduce expression of dux4 |
PT3725786T (pt) | 2017-12-13 | 2023-10-17 | Genfleet Therapeutics Shanghai Inc | Forma cristalina e forma salina de inibidor de tgf-bri e método de preparação das mesmas |
WO2023084459A1 (en) | 2021-11-15 | 2023-05-19 | Pfizer Inc. | Methods of treating sars-cov-2 |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3755332A (en) * | 1971-07-01 | 1973-08-28 | Ciba Geigy Corp | Substituted 4 indazolaminoquinolines |
JPS5998060A (ja) | 1982-11-27 | 1984-06-06 | Fujisawa Pharmaceut Co Ltd | インダゾ−ル誘導体、その製造法および農薬 |
US4571255A (en) * | 1983-12-29 | 1986-02-18 | Ppg Industries, Inc. | Subsituted phenoxybenzisoxazole herbicides |
US5234942A (en) * | 1984-10-19 | 1993-08-10 | Ici Americas Inc. | Heterocyclic amides and leucotriene antagonistic use thereof |
SU1545940A3 (ru) | 1984-10-19 | 1990-02-23 | Ай-Си-Ай Америказ Инк (Фирма) | Способ получени гетероциклических кислот или их солей |
GB8524157D0 (en) * | 1984-10-19 | 1985-11-06 | Ici America Inc | Heterocyclic amides |
PL265549A1 (en) | 1985-03-26 | 1988-09-01 | The method of manufacture of new heterocyclic amides | |
JPS6368568A (ja) | 1986-09-10 | 1988-03-28 | Otsuka Pharmaceut Factory Inc | p−アミノフエノ−ル誘導体 |
NZ224714A (en) | 1987-06-01 | 1990-03-27 | Janssen Pharmaceutica Nv | Substituted benzotriazole derivatives and pharmaceutical compositions |
IE910278A1 (en) | 1990-02-16 | 1991-08-28 | Ici Plc | Heterocyclic compounds |
EP0586608A1 (en) * | 1991-05-29 | 1994-03-16 | Pfizer Inc. | Tricyclic polyhydroxylic tyrosine kinase inhibitors |
CA2116863A1 (en) * | 1992-07-03 | 1994-01-20 | Sumio Yokota | Condensed heterocyclic derivatives and herbicides |
EP0684235A1 (en) | 1994-05-27 | 1995-11-29 | Mochida Pharmaceutical Co., Ltd. | Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity |
EP0854870B1 (en) | 1995-10-06 | 2009-06-10 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
US6083949A (en) * | 1995-10-06 | 2000-07-04 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
JP3554337B2 (ja) | 1996-09-04 | 2004-08-18 | ファイザー・インク | インダゾール誘導体、およびホスホジエステラーゼ(pde)タイプ4と腫瘍壊死因子(tnf)産生の阻害剤としてのインダゾール誘導体の使用 |
KR100567649B1 (ko) | 1996-09-25 | 2006-04-05 | 아스트라제네카 유케이 리미티드 | 혈관 내피 성장 인자와 같은 성장 인자의 효과를 억제하는 퀴놀린 유도체 |
US6218386B1 (en) * | 1996-11-08 | 2001-04-17 | Dupont Pharmaceuticals | A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor |
US5932570A (en) * | 1996-11-08 | 1999-08-03 | Dupont Pharmaceuticals Company | 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors |
CA2270966A1 (en) | 1996-11-08 | 1998-05-14 | Du Pont Pharmaceuticals Company | 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors |
US5945418A (en) * | 1996-12-18 | 1999-08-31 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
UA73073C2 (uk) | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
PL191111B1 (pl) * | 1997-04-24 | 2006-03-31 | Ortho Mcneil Pharm Inc | Podstawione imidazole, sposób ich wytwarzania, kompozycje zawierające podstawione imidazole oraz ich zastosowanie |
WO1998052941A1 (en) * | 1997-05-22 | 1998-11-26 | G.D. Searle And Co. | PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS |
US6093742A (en) * | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
TR200001079T2 (tr) * | 1997-10-20 | 2000-07-21 | F.Hoffmann-La Roche Ag | Bisiklik kinaz inhibitörleri. |
EP1028953A1 (en) * | 1997-11-03 | 2000-08-23 | Boehringer Ingelheim Pharmaceuticals Inc. | Aromatic heterocyclic compounds as anti-inflammatory agents |
ID24942A (id) | 1997-11-04 | 2000-08-31 | Pfizer Prod Inc | Senyawa terapi aktif yang berdasarkan penggantian bioisoster katekol dengan indazole pada inhibitor pde4 |
ID23921A (id) | 1997-11-04 | 2000-05-25 | Pfizer Prod Inc | Penggantian indazola bioisostere katekol pada senyawa-senyawa aktif untuk terapi |
US6329412B1 (en) * | 1997-11-04 | 2001-12-11 | Pfizer Inc | Bisamidine compounds as antiproliferative agents |
US6589954B1 (en) * | 1998-05-22 | 2003-07-08 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
GB9820767D0 (en) | 1998-09-23 | 1998-11-18 | Cerebrus Ltd | Chemical compounds VIII |
UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
WO2000050425A1 (en) * | 1999-02-22 | 2000-08-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | Polycyclo heterocyclic derivatives as antiinflammatory agents |
SI1165516T1 (en) * | 1999-03-12 | 2005-02-28 | Boehringer Ingelheim Pharmaceuticals Inc. | Heterocyclic urea and related compounds useful as anti-inflammatory agents |
JP2002539206A (ja) * | 1999-03-12 | 2002-11-19 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症剤としての芳香族複素環化合物 |
CA2366012A1 (en) * | 1999-03-29 | 2000-10-05 | Shire Biochem Inc. | Methods of treating leukemia |
AU4063600A (en) * | 1999-04-05 | 2000-10-23 | Merck & Co., Inc. | A method of treating cancer |
ATE264328T1 (de) | 1999-04-21 | 2004-04-15 | Wyeth Corp | Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen |
US6355636B1 (en) * | 1999-04-21 | 2002-03-12 | American Cyanamid Company | Substituted 3-cyano-[1.7],[1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases |
CZ20014126A3 (cs) | 1999-05-21 | 2002-03-13 | Scios Inc. | Indolové deriváty jako inhibitory p38 kinasy |
PE20010306A1 (es) | 1999-07-02 | 2001-03-29 | Agouron Pharma | Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa |
TWI262914B (en) * | 1999-07-02 | 2006-10-01 | Agouron Pharma | Compounds and pharmaceutical compositions for inhibiting protein kinases |
ES2253233T3 (es) * | 1999-07-09 | 2006-06-01 | Boehringer Ingelheim Pharmaceuticals Inc. | Procedimiento para sintesis de compuestos de urea heteroaril sustituidos. |
JP2003523952A (ja) * | 1999-11-27 | 2003-08-12 | ドン ファ ファーマシューティカル インダストリアル カンパニー リミテッド | 新規な3−ニトロピリジン誘導体及び該誘導体を含む製薬組成物 |
WO2001038306A1 (en) | 1999-11-27 | 2001-05-31 | Dong Wha Pharm. Ind. Co., Ltd | Novel 3-nitropyridine derivatives and the pharmaceutical compositions containing said derivatives |
AU4890301A (en) * | 2000-04-17 | 2001-10-30 | Dong Wha Pharmaceutical Industrial Co., Ltd. | 6-methylnicotinamide derivatives as antiviral agents |
EP1341782A2 (en) * | 2000-11-20 | 2003-09-10 | Scios Inc. | Inhibitors of p38 kinase |
US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
US7102009B2 (en) * | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
JP4130774B2 (ja) | 2001-03-09 | 2008-08-06 | ファイザー・プロダクツ・インク | 抗炎症薬としてのトリアゾロピリジン類 |
US7199147B2 (en) * | 2001-06-12 | 2007-04-03 | Dainippon Sumitomo Pharma Co., Ltd. | Rho kinase inhibitors |
CZ2004359A3 (cs) | 2001-09-26 | 2004-09-15 | Pharmacia Italia S.P.A. | Aminoindazolové deriváty aktivní jako inhibitory kinázy, způsob jejich přípravy a farmaceutické prostředky obsahující tyto deriváty |
WO2003032989A1 (en) | 2001-10-18 | 2003-04-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
WO2003051847A1 (en) | 2001-12-19 | 2003-06-26 | Smithkline Beecham P.L.C. | (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors |
DE60319066T2 (de) * | 2002-02-25 | 2009-02-26 | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | 1,4-disubstituierte benzokondensierte cycloalkyl-harnstoffverbindungen zur behandlung von zytokinvermittelten erkrankungen |
FR2836915B1 (fr) | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
FR2836914B1 (fr) * | 2002-03-11 | 2008-03-14 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
WO2003087072A1 (fr) | 2002-03-29 | 2003-10-23 | Mochida Pharmaceutical Co., Ltd. | Agent therapeutique destine a des troubles endotheliaux |
CA2492911A1 (en) * | 2002-07-19 | 2004-01-29 | Memory Pharmaceuticals Corporation | 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
AU2003278249B8 (en) | 2002-09-05 | 2010-11-18 | Aventis Pharma S.A. | Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
RU2005115842A (ru) | 2002-10-24 | 2006-03-10 | Мерк Патент ГмбХ (DE) | Производные метиленмочевины |
US7737153B2 (en) * | 2002-10-28 | 2010-06-15 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
US7196082B2 (en) * | 2002-11-08 | 2007-03-27 | Merck & Co. Inc. | Ophthalmic compositions for treating ocular hypertension |
WO2004052280A2 (en) | 2002-12-10 | 2004-06-24 | Imclone Systems Incorporated | Anti-angiogenic compounds and their use in cancer treatment |
US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
US7521447B2 (en) * | 2003-03-03 | 2009-04-21 | Array Biopharma Inc. | P38 inhibitors and methods of use thereof |
GB0320244D0 (en) | 2003-05-06 | 2003-10-01 | Aventis Pharma Inc | Pyrazoles as inhibitors of tumour necrosis factor |
US7129252B2 (en) * | 2003-06-16 | 2006-10-31 | Guoqing P Chen | Six membered amino-amide derivatives an angiogenisis inhibitors |
SE0301906D0 (sv) | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | New compounds |
WO2005004818A2 (en) | 2003-07-09 | 2005-01-20 | Imclone Systems Incorporated | Heterocyclic compounds and their use as anticancer agents |
MXPA06002853A (es) | 2003-09-11 | 2006-06-14 | Kemia Inc | Inhibidores citoquina. |
CA2547837A1 (en) | 2003-12-18 | 2005-07-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Polymorph of birb 796, a p38map kinase inhibitor |
EP1699783B1 (en) | 2003-12-22 | 2012-07-25 | Eli Lilly And Company | Opioid receptor antagonists |
WO2006122230A1 (en) * | 2005-05-11 | 2006-11-16 | Array Biopharma Inc. | P38 inhibitors and methods of use thereof |
EP1981851B1 (en) | 2006-01-31 | 2012-01-25 | Array Biopharma, Inc. | Kinase inhibitors and methods of use thereof |
-
2007
- 2007-01-26 EP EP07762713A patent/EP1981851B1/en active Active
- 2007-01-26 JP JP2008553277A patent/JP5131990B2/ja active Active
- 2007-01-26 RS RS20120119A patent/RS52298B/en unknown
- 2007-01-26 BR BRPI0707401A patent/BRPI0707401B8/pt active IP Right Grant
- 2007-01-26 RU RU2008135332/04A patent/RU2442777C2/ru active
- 2007-01-26 UA UAA200810690A patent/UA94733C2/ru unknown
- 2007-01-26 AU AU2007210073A patent/AU2007210073B2/en active Active
- 2007-01-26 PL PL07762713T patent/PL1981851T3/pl unknown
- 2007-01-26 NZ NZ570846A patent/NZ570846A/en unknown
- 2007-01-26 CA CA2635813A patent/CA2635813C/en active Active
- 2007-01-26 SI SI200730895T patent/SI1981851T1/sl unknown
- 2007-01-26 MY MYPI20082836 patent/MY151835A/en unknown
- 2007-01-26 US US12/161,412 patent/US8044083B2/en active Active
- 2007-01-26 DK DK07762713.1T patent/DK1981851T3/da active
- 2007-01-26 AT AT07762713T patent/ATE542800T1/de active
- 2007-01-26 WO PCT/US2007/002272 patent/WO2007089646A1/en active Application Filing
- 2007-01-26 CN CN2007800120196A patent/CN101415685B/zh active Active
- 2007-01-26 ES ES07762713T patent/ES2379656T3/es active Active
- 2007-01-26 PT PT07762713T patent/PT1981851E/pt unknown
- 2007-01-26 SG SG2011073152A patent/SG175599A1/en unknown
- 2007-01-26 KR KR1020087021184A patent/KR101357465B1/ko active IP Right Grant
- 2007-01-30 TW TW096103341A patent/TWI388557B/zh active
-
2008
- 2008-07-22 IL IL192949A patent/IL192949A/en active IP Right Grant
- 2008-07-25 ZA ZA200806507A patent/ZA200806507B/xx unknown
-
2009
- 2009-01-23 HK HK09100807.4A patent/HK1123548A1/xx unknown
-
2011
- 2011-02-03 US US13/020,578 patent/US8039639B2/en active Active
-
2012
- 2012-03-19 CY CY20121100291T patent/CY1112770T1/el unknown
- 2012-03-21 HR HR20120256T patent/HRP20120256T1/hr unknown
- 2012-05-08 IL IL219643A patent/IL219643A/en active IP Right Grant
- 2012-05-08 IL IL219644A patent/IL219644A/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL219643A0 (en) | Kinase inhibitors and methods of use thereof | |
MX2009006756A (es) | Derivados de 1-amino-metil-l-fenil-ciclohexano como inhibidores de dpp-iv. | |
MX2010009739A (es) | Inhibidores de cinasa pim y metodos para su uso. | |
MY148107A (en) | Kinase inhibitor | |
NZ595572A (en) | Inhibitors of pi3 kinase and / or mtor | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
MY153727A (en) | Pyridazinone derivatives | |
MX2009003157A (es) | Pirazoliltienopiridinas terapeuticas. | |
SI2120932T1 (sl) | Indazolni derivati kot kinazni inhibitorji za zdravljenje raka | |
MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
TNSN08178A1 (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
MY155719A (en) | 2-benzylpyridazinone derivatives as met kinase inhibitors | |
UA84929C2 (en) | Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors | |
MX2009002842A (es) | Inhibidores heterociclicos de c-met y usos de los mismos. | |
MX2011011764A (es) | Compuestos de carboxamida y su uso como inhibidores de calpaina. | |
GEP20125389B (en) | Substituted pyrazole and triazole compounds as ksp inhibitors | |
ZA201003352B (en) | Heterocyclic derivatives as modulators of ion channels | |
HK1162502A1 (en) | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3 | |
MX2010003563A (es) | Inhibidores de proteina cinasa de c-met. | |
WO2007136741A3 (en) | N-desmethyl-doxepin and methods of using the same to treat sleep disorders | |
UA109793C2 (uk) | Арилсульфонаміди для лікування захворювань центральної нервової системи (цнс) | |
MX2011012524A (es) | Inhibidores de proteina cinasa c-met. | |
WO2009015000A8 (en) | Pyrazole urea derivatives used as kinase inhibitors | |
MY145122A (en) | Phenylacetic acid derivatives as cox-2 inhibitors |